Time New York: Sat 03 Dec 01:51 am  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Heat Biologics (HTBX) in Focus: Stock Moves 30.4% Higher

Zacks

Heat Biologics, Inc. HTBX was a big mover last session, as its shares rose over 30% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.28 to $1.91 in the past one-month time frame.

Over the last 30 days, the company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Heat Biologics currently carries a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

HEAT BIOLOGICS Price


HEAT BIOLOGICS Price | HEAT BIOLOGICS Quote

A similar-ranked stock in the medical-drugs space is Sucampo Pharmaceuticals, Inc. SCMP, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is HTBX going up? Or down? Predict to see what others think: Up or Down

Zacks’ Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.